CACLP 2026 (China Association of Clinical Laboratory Practice)

Choose a country to view content specific to your location

CACLP 2026 (China Association of Clinical Laboratory Practice)

Immuno, Molecular
Asia Pacific

21 — 23 March 2026

Join us at Booth #4-0606 for CACLP 2026, the 23rd China International In Vitro Diagnostic Expo, taking place 21–23 March 2026 at the Xiamen International Expo Center, Xiamen, China.

As one of the largest and most influential IVD exhibitions in China, CACLP provides a comprehensive platform for industry professionals, researchers, and businesses to explore the latest advancements across the diagnostics ecosystem—including diagnostic technologies, medical laboratory equipment, and cutting-edge innovations.

At CACLP 2026, we are proud to launch our newest liquid ambient-stable qPCR and RT-qPCR mixes, delivering outstanding performance and stability without the need for cold-chain logistics. We will also introduce our recombinant HAMA blockers, specifically engineered to reduce assay interference and enhance result reliability.

Discover our comprehensive portfolio of molecular and immunoassay solutions, thoughtfully designed to simplify assay development and support more sustainable workflows. Our offerings include high-quality antigens, antibodies, blockers, molecular enzymes, nucleotides, and optimized mixes for qPCR, isothermal amplification, and NGS applications. Visit our booth and attend our seminar presentation to learn how these innovations can advance your diagnostic development programs.

This is a unique opportunity to connect, collaborate, and stay ahead in the rapidly evolving diagnostics landscape—don’t miss it！

Xiamen International Expo Center, Xiamen, China
Booth #4-0606

Join Us For Our Seminars

Official Launch of Meridian Liquid Ambient Stable qPCR/RT-qPCR Mixes: Driving Global Market Entry and Cost Efficiency for Chinese IVD Companies

March 21st, 2026 | 13:00-14:00 Beijing Time CST | Location: Room 13, Level 2 in Hall 4

Join us for the official launch of Meridian’s newest liquid ambient-stable qPCR and RT-qPCR mixes, designed to eliminate cold-chain requirements while delivering exceptional sensitivity, specificity, and reproducibility.

This talk will highlight the innovative technology behind our ambient-stable formulations and demonstrate how they enable simplified logistics, lower transportation and storage costs, and enhanced supply chain flexibility. We will also explore how ready-to-use liquid formats improve manufacturing efficiency and performance consistency—empowering Chinese IVD companies to accelerate regulatory readiness and confidently expand into global markets.

About The Speaker

Alpha completed a Bachelor’s degree in Biochemistry from the University of Canterbury, New Zealand, followed by a Master’s in Biomedical Science. With prior experience in various commercial laboratories in New Zealand, Alpha specialized in testing and product development. Since joining Meridian in 2015, Alpha has held multiple roles in product development, production, and QA/QC. Currently, Alpha oversees marketing and molecular product support in China for Meridian Bioscience.

<b>Alpha Chen</b></br>Senior Product Specialist, Meridian Life Science

Alpha Chen
Senior Product Specialist, Meridian Life Science

Addressing False Positives in Immunoassays: Interference Elimination Strategies for High-Sensitivity Cardiac and TORCH Assay Development

March 21st, 2026 | 14:20-15:00 Beijing Time CST | Location: Room 13, Level 2 in Hall 4

As immunoassays become more sensitive, false positives caused by heterophilic antibodies, HAMA, and other endogenous interferents increasingly impact assay accuracy—particularly in high-sensitivity cardiac and TORCH testing.

This talk will explore key interference mechanisms and effective mitigation strategies. We will also officially launch our new recombinant HAMA blocker, designed to deliver consistent interference control while supporting more sustainable and supply-secure manufacturing. Join us to learn how advanced blocking solutions can enhance assay reliability and diagnostic confidence.

About The Speaker

Zichen holds a Ph.D. in Biochemistry from East China University of Science and Technology. With extensive experience in immunoassay development, Zichen previously worked in R&D at Shanghai Fosun Long March Medical Science Co., Ltd. and Shanghai Kehua Bio-Engineering Co., Ltd. Zichen joined Meridian in 2021 and is a Business Development Manager at Meridian Life Science, China.